Eli Lilly's CFO explains why the company's newest weight loss drug Zepbound will cost 20% less than the current options
Zepbound is expected to be available in the U.S. by the end of the year.
Source: fortune.com
Stay updated with breaking news from Finance Chief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zepbound is expected to be available in the U.S. by the end of the year.
Generative AI can be a tool used to “reimagine your business and your industry,” Alexander Sukharevsky said.
The wage premium is strongly correlated with gains in productivity.
AI is still accelerating at a rapid pace, and for some companies, there's a fear of missing out.
"Forty percent of my variable remuneration is tied to climate actions and reputation," Claus Aagaard says.